Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
Article in Scientific Reports (December 2022)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
Preprint in Research Square (July 2022)
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
Article in Nagoya Journal of Medical Science (November 2021)